Skip to main content
Premium Trial:

Request an Annual Quote

The BioCommerce Week Index: Feb 24, 2005

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(Feb. 22, 2005)
Last Price
(
Feb. 15, 2005)
% Change
Agilent
A
23.48
24.39
-3.73
Applied Biosystems
ABI
19.75
20.57
-3.99
BD
BDX
58.67
59.39
-1.21
Beckman
BEC
68.11
68.85
-1.07
Bio-Rad
BIO
47.48
57.75
-17.78
Bruker
BRKR
3.75
4.00
-6.25
GE
GE
35.35
36.39
-2.86
Harvard Bio
HBIO
4.62
4.65
-0.65
Invitrogen
IVGN
68.74
71.64
-4.05
Molecular Devices
MDCC
20.37
21.32
-4.46
PerkinElmer
PKI
22.28
22.88
-2.62
Sigma
SIAL
61.06
62.71
-2.63
Stratagene
STGN
6.59
6.74
-2.23
Thermo
TMO
27.14
27.38
-0.88
Waters
WAT
48.03
49.91
-3.77
Index Average
34.36
35.90
-4.30

 

Bio-Rad Falls 17 Percent on Q4 Report;
BCW Index Down 4 Percent for the Week

Investors came back from the President's Day holiday to produce the most active day of trading so far this year on Tuesday, sending the Dow and S&P 500 indexes to 1.4 percent losses in the biggest one-day drop since August. Market watchers attributed the move to cold weather in North America and a potential for higher oil prices.

Market conditions affected the BioCommerce Week Index too. For the first time since the tracking index of the multiplatform molecular biology tools companies was launched on Sept. 9, all company's shares were down for the five-day period ending Tuesday.

Bio-Rad, which last week reported an 11-percent drop in earnings for its fourth quarter (see related story), led all losers with an 18-percent drop in its share price, closing Tuesday at $47.48, down from last week's $57.75.

Bruker BioScience shares fell 6 percent, Molecular Devices fell 4.5 percent, and Invitrogen, which also reported its fourth-quarter results last week (see related story), and Applied Biosystems dropped 4 percent. In the 3-percent bracket were Waters and Agilent at 3.8 percent down, followed by GE at 3, then Sigma-Aldrich at 2.6 percent, and Stratagene at 2 percent. BD and Beckman each lost 1 percent while Thermo and Harvard Bio were off by a fraction.

Overall, the BCW Index fell 4 percent to close at $34.36 for the five-day period, two weeks after reaching a high of $36.10. The Index trailed the Dow, which closed down 1.5 percent for the period; the S&P, which fell 1.8 percent; and the Nasdaq, which was down 2.6 percent for the week. The Amex biotech index finished down 1.8 percent for the week, while the Amex pharma index closed up 1 percent for the period.

Following is a schedule of quarterly financial reporting dates for the BCW Index companies:

  • Bruker BioScience: March 2
  • Harvard Bioscience: March 4
  • Stratagene: No date set

 

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.